Elucidating the molecular mechanisms of small-molecule disruption of viral replication machinery

Information

  • Research Project
  • 10234178
  • ApplicationId
    10234178
  • Core Project Number
    P20GM104316
  • Full Project Number
    5P20GM104316-07
  • Serial Number
    104316
  • FOA Number
    PAR-19-312
  • Sub Project Id
    6822
  • Project Start Date
    9/1/2014 - 9 years ago
  • Project End Date
    6/30/2025 - a year from now
  • Program Officer Name
  • Budget Start Date
    7/1/2021 - 2 years ago
  • Budget End Date
    6/30/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    07
  • Suffix
  • Award Notice Date
    8/12/2021 - 2 years ago
Organizations

Elucidating the molecular mechanisms of small-molecule disruption of viral replication machinery

5. Elucidating the molecular mechanisms of small-molecule disruption of viral replication machinery Project Leader: Juan Perilla (CBC) Computational modeling and simulations provide a powerful toolset to determine the atomistic mechanisms underlying biological processes, such as those that occur during the life cycle of a pathogen. Likewise, computational methods can be leveraged to reveal the mechanisms by which these processes are altered or disrupted by small-molecule therapeutics. The work proposed here aims to elucidate the chemical and physical effects of small molecules on the replication machinery essential to a highly relevant human pathogen, namely HIV-1. Despite the success of several antiretrovirals, the virus has evolved resistance to all known drugs. Remarkably, not a single drug has been developed against large protein assemblies like the viral capsid therefore providing an unexploited therapeutic target. The work proposed here aims to elucidate the chemical and physical effects of small molecules on the capsid-related replication machinery essential to HIV. Importantly, the proposed work is not only relevant for HIV patients as HIV serves as a model for other human diseases, including virus-related cancer. In addition, the cutting-edge methods developed herein will be directly applicable to other virus and bacterial assemblies.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    P20
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
    129999
  • Indirect Cost Amount
    66725
  • Total Cost
  • Sub Project Total Cost
    196724
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NIGMS:196724\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZGM1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF DELAWARE
  • Organization Department
  • Organization DUNS
    059007500
  • Organization City
    NEWARK
  • Organization State
    DE
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    197160000
  • Organization District
    UNITED STATES